- Latest available (Revised)
- Original (As made)
The Health Service Products (Provision and Disclosure of Information) Regulations 2018
You are here:
- UK Statutory Instruments
- 2018 No. 677
- SCHEDULE 4
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Changes to legislation:
There are currently no known outstanding effects for the The Health Service Products (Provision and Disclosure of Information) Regulations 2018, SCHEDULE 4.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 34
SCHEDULE 4U.K.Disclosure of information under section 246B of the 2006 Act: prescribed bodies and prescribed purposes
This schedule has no associated Explanatory Memorandum
1.—(1) The bodies specified in column 1 of Table 1, being bodies appearing to the Secretary of State to represent UK producers, are prescribed for the purposes of section 264B(1)(k) of the 2006 Act.U.K.
(2) The purpose for which a body specified in column 1 of Table 1 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.
Table 1
| Column 1 – Bodies | Column 2 – The purpose for which information disclosed under section 264B(1) of the 2006 Act may be used |
|---|---|
Association of British Healthcare Industries; Association of Pharmaceutical Specials Manufacturers; British Association of European Pharmaceutical Distributors; British Generic Manufacturers Association; British Healthcare Trades Association; British In Vitro Diagnostics Association; Healthcare Distribution Association; NHS Pharmacy Production Committee; NHS Pharmaceutical Quality Assurance; Proprietary Association of Great Britain; Surgical Dressings Manufacturers Association Committee; Urology Trade Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (l). |
Association of Independent Multiple Pharmacies; Company Chemists' Association; National Pharmacy Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (k). |
BioIndustry Association; Ethical Medicines Industry Group. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i), (l) and (m). |
| Association of the British Pharmaceutical Industry | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i) and (k) to (m). |
British Medical Association; Dispensing Doctor's Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a), (c), (d), (f), (g) and (i) to (k). |
| Pharmaceutical Services Negotiating Committee | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(b) and (c). |
2.—(1) The bodies specified in column 1 of Table 2 are prescribed for the purposes of section 264B(1)(l) of the 2006 Act.U.K.
(2) The purpose for which a body specified in column 1 of Table 2 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.
Table 2
| Column 1 – Bodies | Column 2 – Purpose for which information disclosed under section 264B(1) of the 2006 Act may be used |
|---|---|
Any NHS foundation trust; Any NHS trust established under the 2006 Act; Any [F1integrated care board]. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c). |
Any NHS trust established under the 2006 Wales Act; Any Local Health Board. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(f). |
| Any Health Board constituted under section 2 of the 1978 Act | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(i). |
| The Regional Health and Social Care Board established under section 7 of the Health and Social Care (Reform) Act Northern Ireland 2009 M1 | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(k). |
Textual Amendments
F1Words in Regulations substituted (1.7.2022) by The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 (S.I. 2022/634), reg. 1(2), Sch. para. 1(1)(3) (with Sch. para. 1(2))
Marginal Citations
Options/Help
Print Options
PrintThe Whole Instrument
PrintThis Schedule only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Impact Assessments
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
- Why the government is proposing to intervene;
- The main options the government is considering, and which one is preferred;
- How and to what extent new policies may impact on them; and,
- The estimated costs and benefits of proposed measures.
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.